Literature DB >> 337095

Optimal use of L-asparaginase (NSC-109229) in acute lymphocytic leukemia.

B Jones, J F Holland, O Glidewell, C Jacquillat, M Weil, C Pochedly, L Sinks, L Chevalier, H M Maurer, K Koch, G Falkson, R Patterson, B Seligman, J Sartorius, F Kung, F Haurani, M Stuart, E O Burgert, F Ruymann, A Sawitsky, E Forman, H Pluess, J Truman, N Hakami.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 337095     DOI： 10.1002/mpo.2950030410

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN： 0098-1532


× No keyword cloud information.
  12 in total

Review 1.  Pharmacogenomics in pediatric leukemia.

Authors:  Steven W Paugh; Gabriele Stocco; William E Evans
Journal:  Curr Opin Pediatr       Date:  2010-12       Impact factor: 2.856

2.  Evaluation of different induction regimens in children with acute lymphocytic leukemia.

Authors:  V P Choudhry; L S Arya
Journal:  Indian J Pediatr       Date:  1988 Sep-Oct       Impact factor: 1.967

3.  Evaluation of prednisolone and vincristine with and without L-asparaginase in acute lymphatic leukemia of childhood.

Authors:  V P Choudhry; R K Marwaha; D P Goyal; A K Sarya
Journal:  Indian J Pediatr       Date:  1983 Nov-Dec       Impact factor: 1.967

4.  Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group.

Authors:  Wanda L Salzer; Barbara Asselin; Jeffrey G Supko; Meenakshi Devidas; Nicole A Kaiser; Paul Plourde; Naomi J Winick; Gregory H Reaman; Elizabeth Raetz; William L Carroll; Stephen P Hunger
Journal:  Blood       Date:  2013-06-05       Impact factor: 22.113

Review 5.  Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention.

Authors:  V B Pai; M C Nahata
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

6.  Nation-wide randomized comparative study of doxorubicin, vincristine and prednisolone combination therapy with and without L-asparaginase for adult acute lymphoblastic leukemia.

Authors:  E Nagura; K Kimura; K Yamada; K Ota; T Maekawa; F Takaku; H Uchino; T Masaoka; I Amaki; K Kawashima
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

7.  Intermediate-dose methotrexate in the treatment of childhood acute lymphocytic leukaemia: lack of benefit during maintenance therapy following intensive induction therapy.

Authors:  G E Janka-Schaub; K Winkler; H Jürgens; U Goebel; P Gutjahr; H J Spaar
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

Review 8.  Pharmacokinetics of anticancer drugs in children.

Authors:  W R Crom; A M Glynn-Barnhart; J H Rodman; M E Teresi; R E Kavanagh; M L Christensen; M V Relling; W E Evans
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

9.  Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis.

Authors:  Susan L Kearney; Suzanne E Dahlberg; Donna E Levy; Stephan D Voss; Stephen E Sallan; Lewis B Silverman
Journal:  Pediatr Blood Cancer       Date:  2009-08       Impact factor: 3.167

10.  First-line treatment of acute lymphoblastic leukemia with pegasparaginase.

Authors:  Riccardo Masetti; Andrea Pession
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.